Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the decision by Pfizer to make changes to manufacturing processes of its covid-19 vaccine to boost production will affect the distribution of that vaccine to the UK from late January to early February 2021.

Vaccines are a precious resource and are in very high demand across the world; therefore, for security reasons it is not possible to provide detail about the size of our supplies or give exact detail about future deliveries.

We have been monitoring the requirements across the supply chain from supplier through to patients for some time. All vaccine candidates’ supply and onward deployment have clear supply chain plans across the value chain, including materials, manufacturing, transportation, storage, and distribution.

As of 18 January 2021, over 4.6 million people in the UK had been vaccinated with the first dose of the vaccine. We are in the process of understanding the implications of Pfizer’s announcement on 15 January regarding upgrades to its manufacturing capacity. We continue to work to meet our target of vaccinating all four priority groups, as advised by the Joint Committee on Vaccination and Immunisation, by the middle of February.